Program Description:
Venous Thromboembolism (VTE) is a common vascular disease and significant public health problem. Deep vein thrombosis (DVT) and pulmonary embolism (PE), the most common manifestations of VTE, are estimated to occur in up to 2 million Americans each year and are responsible for more deaths than breast cancer, highway fatalities, and AIDS combined. Despite the availability and effectiveness of prophylactic therapies for VTE and evidence-based guidelines for their use, results from multiple studies indicate that VTE prophylaxis remains underutilized in at-risk populations in both the inpatient and outpatient settings. Orthopedic and cancer patients are at particular risk for outpatient VTE.
This enduring CME activity will focus on strategies for ensuring the safe transition of at-risk patients from the inpatient to outpatient setting, will provide guidance for the safe and effective use of antithrombotic therapy in the outpatient setting, and will present strategies for overcoming barriers to outpatient VTE prophylaxis.
Activity Objectives:
After participating in this activity, clinicians should be better able to:
- Describe the ACCP guideline recommendations and the importance for continuity of care with respect to VTE prophylaxis as patients transiting from inpatient to outpatient setting.
- Describe the JCAHO/NQF National Consensus Standards for Prevention and Care of VTE.
- Identify barriers to outpatient VTE prophylaxis and implement strategies to overcome them.
- Identify best practices for an outpatient VTE prophylaxis program.
Target Audience:
This activity is intended for orthopedic surgeons, hematology/oncology physicians, hospitalists, internists, nurse practitioners, physician assistants, nurses, case managers, pharmacists, anticoagulation clinic staff, and other healthcare providers involved in the management of patients at risk for venous thromboembolism
|
Credits
|
Type
|
Accreditation Statement
|
Designation Statement
|
|
2.00
|
AMA PRA Category 1 Credit(s)™
|
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The University of Cincinnati in partnership with CME Horizon. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
|
The University of Cincinnati designates this educational activity for a maximum of 2.0
|
|
1.00
|
CE for Nurses
|
This continuing nursing education activity was approved by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
|
This CE activity provides 1.00 contact hours.
|
|
2.00
|
CE for Pharmacists
|
 This program has been planned and implemented in accordance with the policies of the Accreditation Council on Pharmaceutical Education through the sponsorship of the Oregon State University College of Pharmacy.
The Oregon State University College of Pharmacy is approved by the Accreditation Council on Pharmaceutical Education as a provider of continuing pharmaceutical education.
|
The Oregon State University College of Pharmacy designates this continuing education activity for 2.00 contact hour (0.20 CEUs) of the Accreditation Council for Pharmacy Education. UPN # - 0036-9999-10-011-C01-P
|
Faculty:
Franklin A. Michota, MD, FACP,FHM - Chair
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Director of Academic Affairs
Department of Hospital Medicine
Cleveland Clinic
Craig M. Kessler, MD, MACP
Professor of Medicine and Pathology
Georgetown University Medical Center
Director of the Division of Coagulation
Department of Laboratory Medicine
Lombardi Comprehensive Cancer Center
Washington, DC
Edith A. Nutescu, PharmD, FCCP
Clinical Professor
Department of Pharmacy Practice and Center for Pharmacoeconomic Research
Director, Antithrombosis Center
University of Illinois at Chicago
College of Pharmacy and Medical Center
Chicago, Illinois
Disclosures:
Disclosure of Conflicts of Interest
University of Cincinnati assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by University of Cincinnati for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. University of Cincinnati is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Franklin A Michota, MD is a consultant for sanofi-aventis, is a board member for the Hospital Quality Foundation, and serves on speakers bureau for sanofi-aventis, Genentech, and Otsuka.
Craig M. Kessler, MD is on an advisory board for Eisai Pharmaceuticals and sanofi-aventis. He is a consultant for Eisai Pharmaceuticals, sanofi-aventis, and Canyon Pharmaceuticals. He has received research grants from Eisai Pharmaceuticals, sanofi-aventis, and Canyon Pharmaceuticals. He serves on speakers bureau for sanofi-aventis and GlaxoSmithKline.
Edith A. Nutescu, PharmD is a consultant for Baxter, sanofi-aventis, and APP Pharmaceuticals. She has received research grants from Ortho McNeil Johnson. She serves on speakers bureau for Eisai Pharmaceuticals and sanofi-aventis.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
All planners and managers of University of Cincinnati and Horizon CME hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. University of Cincinnati or Horizon CME do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of University of Cincinnati or Horizon CME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This program is jointly sponsored by the University of Cincinnati and Horizon CME
If you have any questions relating to the accreditation of this activity, please contact
Elizabeth Hill, CHES – Elizabeth.hill@horizoncme.com – 503.775.5799
Instructions:
To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.